Trial Profile
Phase I trial of the tolerability and pharmacokinetics of tedatioxetine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2007
Price :
$35
*
At a glance
- Drugs Tedatioxetine (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- Sponsors Lundbeck A/S
- 24 Oct 2007 A positive conclusion to the study has been reported (9081465)
- 24 Oct 2007 Status changed from initiated to completed
- 08 Feb 2006 New trial record.